Beginnings of Personalized Medicine for Myeloma

Ajai Chari, MD

Video Categories: Personalized Medicine

Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.

Related Videos

July 29, 2015

Targeted Therapies and their Impact on Melanoma

Dr. Steve O’Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.

January 4, 2017

Describing Side Effects on IV Therapy

Wouter de Herder, MD, discusses transient and long-term side effects for patients undergoing this type of treatment.